Table 4:
Multivariate Logistic Regression Analysis of HCV Screening and Selection of Point-of-Care HCV Testing among Clients on a Mobile Medical Clinic in New Haven, Connecticut, 2012-2013 (N=1345).
| Outcome: Decision to Accept HCV Ab Screening N=1345 |
Outcome: Choosing Point-of-Care HCV Ab Screen versus Standard Phlebotomy N=438 |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Covariate | AOR | (95% CI) | Marginal Effects (dy/dx) | p-value | Covariate | AOR | (95% CI) | Marginal Effects (dy/dx) | p-value |
| Prior STI | 5.03 | (1.76,14.26) | 0.36 | <0.01 | > 15 sex partners | 5.84 | (3.14, 10.8) | 0.41 | <0.01 |
| Non-Hispanic White | 0.55 | (0.36,0.78) | −0.11 | <0.01 | Non-Hispanic White | 3.21 | (1.58, 5.96) | 0.27 | <0.01 |
| Non-Hispanic Black | 0.76 | (0.53, 1.09) | −0.05 | 0.13 | Non-Hispanic Black | 1.15 | (0.62, 1.85) | 0.04 | 0.65 |
| Hispanic | Referent | Hispanic | Referent | ||||||
| US-born | 1.76 | (1.25,2.46) | 0.12 | <0.01 | US-born | 2.31 | (1.26, 3.68) | 0.21 | <0.01 |
| Injection Drug Use (PWID) |
2.21 | (1.12,4.46) | 0.14 | 0.03 | Injection Drug Use (PWID) |
0.31 | (0.19, 1.01) | −0.20 | 0.01 |
| Baby Boomer | 0.67 | (0.46,0.97) | −0.07 | 0.04 | |||||
| Prior HCV Diagnosis | 1.94 | (0.94,4.31) | 0.16 | 0.09 | Prior HCV Diagnosis | 2.10 | (0.67, 6.58) | 0.18 | 0.2 |
| Non-injection Drug Use | 0.71 | (0.82,1.97) | 0.05 | 0.23 | |||||
| Unstable | 0.76 | (0.50,1.19) | −0.04 | 0.21 | |||||
| Housing | |||||||||
| Median AIC: 1392 | Median AIC: 67 | ||||||||
LEGEND: HCV: Hepatitis C Virus; HCV Ab: Hepatitis C Antibody; STI: Sexually Transmitted Infection; AOR: Adjusted Odds Ratio; CI: Confidence Interval; PWID: People Who Inject Drugs; AIC: Akaike Information Criterion; Covariates significant at the p<0.05 level are boldfaced.